Heritage Pharmaceuticals teams with Ipca Laboratories to release generic cardio drug

NEW DELHI Indian drug maker Ipca Laboratories has entered an alliance with Heritage Pharmaceuticals, based in Edison, N.J.

Under the alliance, Ipca will manufacture the cardiovascular drug propranolol hydrochloride, while both companies will collaborate to market it.

Propranolol is a generic version of Schering’s Inderal. Branded and generic versions of the drug had sales in the United States of $25 million in 2007, according to IMS Health.

Login or Register to post a comment.